Vasa-european Journal of Vascular Medicine最新文献

{"title":"Acceptance, drivers and barriers of digital discharge management interventions among patients with cardiovascular disease.","authors":"Finley Sam Mellis, Alexander Bäuerle, Simone Peters, Matthias Marsall, Lisa Maria Jahre, Tienush Rassaf, Christos Rammos, Christoph Jansen, Martin Teufel, Julia Lortz, Muhammed Kurt","doi":"10.1024/0301-1526/a001275","DOIUrl":"https://doi.org/10.1024/0301-1526/a001275","url":null,"abstract":"<p><p><b></b> <i>Background:</i> Cardiovascular diseases (CVD) are the leading cause of mortality worldwide. Unplanned rehospitalisation rates after discharge remain high, reflecting the chronic nature of CVD and the frequent need for complex, multidisciplinary follow-up care. Digital interventions may provide a valuable complement to traditional discharge management in addressing these challenges. <i>Patients and methods:</i> This study aims to assess the acceptance of digital discharge management interventions (DDMI) and to investigate the underlying factors influencing acceptance among patients with CVD following inpatient treatment. A cross-sectional survey-based study was conducted from June to October 2024 with N = 259 patients with CVD following inpatient treatment. Sociodemographic, medical, mental health, and e-Health-related data were assessed. Acceptance of DDMI and its underlying factors were assessed using a modified model of the Unified Theory of Acceptance of Use of Technology (UTAUT). <i>Results:</i> The overall acceptance of DDMI was high (M = 3.99, SD = 0.92, range = 1-5). The extended UTAUT model explained 62.7% of the variance in acceptance, with male gender (β = -0.36, p < .001) and the UTAUT predictors effort expectancy (β = 0.40, p < .001), performance expectancy (β = 0.24, p < .001), and social influence (β = 0.20, p < .001) being significant predictors. <i>Conclusions:</i> These findings indicate a generally high acceptance of DDMI among patients with CVD following inpatient treatment. To develop and implement such interventions, key drivers and barriers such as effort expectancy, performance expectancy, and social influence should be addressed. Furthermore, such interventions should be tailored to patients' specific needs.</p>","PeriodicalId":23528,"journal":{"name":"Vasa-european Journal of Vascular Medicine","volume":" ","pages":""},"PeriodicalIF":2.4,"publicationDate":"2026-02-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147310566","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Feasibility of obtaining endothelial cells from major surgery and critically ill patients.","authors":"Charles Piercy, Naomi Boyer, Syed Muhammad Tahir Nasser, Syeda Fizza Haider, Alice Extance, Kelly Broderick, Idrisu Sanusi, Emma Brown, Justin Duruanyanwu, Paola Campagnolo, Christian Heiss, Ben Creagh-Brown","doi":"10.1024/0301-1526/a001264","DOIUrl":"https://doi.org/10.1024/0301-1526/a001264","url":null,"abstract":"<p><p><b></b> <i>Background:</i> Endothelial cell biopsy (ECBx) is a promising tool to obtain endothelial cells (EC) for research purposes from a range of patients, however the minimally invasive procedure has not been described in the critically ill. Our study set out to demonstrate the feasibility of performing ECBx using discarded guidewires used as part of standard care (SOC). <i>Patients and methods:</i> Guidewires from central venous catheters (CVC) and arterial lines were collected from surgical patients prior to major surgery (n = 16) and from patients upon admission to the Intensive Care Unit (ICU) (n = 16). In surgical patients, additional ECBx were performed from cubital veins. Quantification and characterization of EC was performed using flow cytometry. <i>Results:</i> A total of 44 wires were collected with a similar yield of EC from standard of care CVC (2,265 IQR881-6,610 /wire, n = 20) and arterial lines (2,109 IQR 1,288-2,682 /wire, n = 13), and purposely performed cubital veins biopsies (2,089 905-3,636 /wire, n = 11; p = .83). Comparison of the phenotype of EC between cohorts showed a significant increase in size (p = .01) and internal complexity (p < .01) of cells in the ICU cohort compared to the surgical cohort. <i>Conclusions</i>: It is feasible to collect EC from discarded guidewires used in SOC. The data demonstrate phenotypic differences between EC between cohorts and that ECBx is a safe and well tolerated technique. Our findings suggest that ECBx can provide valuable insights into clinically relevant EC pathophysiology and may help guide future research.</p>","PeriodicalId":23528,"journal":{"name":"Vasa-european Journal of Vascular Medicine","volume":" ","pages":""},"PeriodicalIF":2.4,"publicationDate":"2026-02-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147310551","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Cholesterol-lowering therapy in patients with symptomatic peripheral arterial disease - real life data in a German population.","authors":"Michelle Hamers, Thomas Nowak, Hinrich Böhner, Thomas Hummel, Marko Aleksic, Dominik Jost, Markus Winkler, Bruno Geier","doi":"10.1024/0301-1526/a001271","DOIUrl":"https://doi.org/10.1024/0301-1526/a001271","url":null,"abstract":"<p><p><b></b> <i>Background:</i> Several studies have shown LDL-Cholesterol to be a main risk-factor in the development of atherosclerosis and that the reduction of LDL-Cholesterol leads to a substantial decrease in cardiovascular morbidity and mortality. Patients with proven PAD are considered to be at very high risk for cardiovascular events and a reduction of LDL-Cholesterol to 55 mg/dl and to 50% of the baseline is recommended in this population. <i>Material and methods:</i> Patients with symptomatic PAD from 7 Vascular Surgery Centres in Germany were included in the study. It was assessed if the patients were on Cholesterol-lowering drugs at admission and the Cholesterol und LDL-Cholesterol levels upon admission were obtained. A total of 884 patients were included in the analysis. <i>Results:</i> Only 537 (61%) patients were on Cholesterol-lowering drug therapy. In this subgroup, Cholesterol levels ≤ 100 mg/dl were found in 384 cases (72%), ≤ 70 mg/dl in 191 (36%) and ≤ 55 mg/dl in 87 (16%) of cases. <i>Conclusions:</i> Despite overwhelming evidence for the beneficial effects of adequate LDL-Cholesterol reduction, only 61% of PAD-patients were on Cholesterol-lowering drug therapy and only 16% achieved the LDL-Cholesterol levels advocated inn recent guidelines. The vascular community must undertake a bigger effort to implement Cholesterol-lowering drug therapy in PAD patients.</p>","PeriodicalId":23528,"journal":{"name":"Vasa-european Journal of Vascular Medicine","volume":" ","pages":""},"PeriodicalIF":2.4,"publicationDate":"2026-02-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147310561","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Endovascular treatment of severely calcified aortoiliac occlusive disease: long-term outcomes from a single-centre cohort.","authors":"Jonas Salm, Sebastian Jurina, Tanja Böhme, Elias Noory, Ulrich Beschorner, Mario Lescan, Dirk Westermann, Thomas Zeller","doi":"10.1024/0301-1526/a001266","DOIUrl":"https://doi.org/10.1024/0301-1526/a001266","url":null,"abstract":"<p><p><b></b> <i>Background:</i> To evaluate safety, technical success, and long-term outcomes of endovascular therapy (EVT) in severely calcified aortoiliac occlusive disease (AIOD), focusing on lesion characteristics and the presence of coral reef aorta (CRA). <i>Patients and methods:</i> This single-center retrospective study included 216 patients with angiographically confirmed calcified abdominal aortic stenosis (mean PACSS 3.7 ± 0.8) treated with EVT between 2005 and 2023. Of these, 33 patients had coral reef aorta (CRA). Patients were stratified by lesion location and CRA presence. Primary endpoints were 30-day adverse events and technical success (residual stenosis <30%). Secondary endpoints were major adverse cardiovascular events (MACE), major adverse limb events (MALE), and all-cause mortality. Cox regression identified predictors of outcome. <i>Results:</i> Technical success was achieved in 81.9%. Thirty-day mortality was 0.5%. At 10 years, freedom from MACE was significantly lower in patients with non-bifurcation abdominal aortic stenosis (56% vs. 76%; aHR 2.13, p < .05) and lowest in CRA (30% vs. 71%; aHR 3.17, p < .05). Independent predictors of MACE were CRA, chronic total occlusion (aHR 3.38, 95% CI 1.57-7.29), critical limb-threatening ischemia (aHR 3.67, 95% CI 1.74-7.75), and age (aHR 1.06 per year, 95% CI 1.01-1.11). MALE was more frequent in patients with peripheral arterial disease (aHR 2.07, 95% CI 1.12-3.81), CRA (aHR 2.51, 95% CI 1.17-5.40), and current smokers (aHR 5.10, 95% CI 1.23-21.0). <i>Conclusions</i>: CRA and non-bifurcation abdominal aortic stenosis are associated with reduced long-term freedom from MACE after EVT. These findings define high-risk subgroups within calcified AIOD and highlight the prognostic value of anatomical lesion characteristics for treatment planning and follow-up.</p>","PeriodicalId":23528,"journal":{"name":"Vasa-european Journal of Vascular Medicine","volume":" ","pages":""},"PeriodicalIF":2.4,"publicationDate":"2026-02-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146214307","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The effects of adding physiotherapy to compression therapy on function and oedema in chronic venous insufficiency.","authors":"Noemí Moreno-Segura, Mario Mateo-Martínez, Mariana Sánchez-Barbadora, Rodrigo Martín-San Agustín","doi":"10.1024/0301-1526/a001262","DOIUrl":"https://doi.org/10.1024/0301-1526/a001262","url":null,"abstract":"<p><p><b></b> <i>Background:</i> To compare the effects of conventional approaches based on compression stockings and preventive measures with a combined program including these techniques, together with therapeutic exercise and self-manual lymphatic drainage instructed by a physiotherapist on functionality, general physical activity, and oedema in individuals with chronic venous insufficiency. <i>Patients and methods:</i> A randomized controlled clinical trial with two parallel groups (conventional approach and conventional plus physiotherapy approach) and a single-blind design was conducted. Oedema (circumferences), functionality (6-Minute Walking Test and the Five-Repetition Sit-to-Stand Test), physical activity level (International Physical Activity Questionnaire), and prevention measures were assessed before and after the intervention. Repeated measures ANOVA was used for statistical analysis. A total of 55 participants composed the final sample (13 women and 42 men, mean age: 60.49 years [15.05]). <i>Results:</i> No significant changes were found for the main effect of time or group-time-adherence interaction in any variable, while circumference at 10, 20, and 30 cm from the heel in both legs, and the 6-Minutes Walking Test showed a significant main effect for time in the conventional-approach group with high adherence. <i>Conclusions:</i> A multicomponent approach combining physiotherapy and medicine does not appear to be better than the conventional approach applied at primary care centres for improving functionality and oedema in patients with chronic venous insufficiency.</p>","PeriodicalId":23528,"journal":{"name":"Vasa-european Journal of Vascular Medicine","volume":" ","pages":""},"PeriodicalIF":2.4,"publicationDate":"2026-01-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145998992","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Web-based lifestyle application as support for secondary prevention in patients with intermittent claudication.","authors":"Rebecka Striberger, Moncef Zarrouk, Malin Axelsson, Christine Kumlien","doi":"10.1024/0301-1526/a001258","DOIUrl":"https://doi.org/10.1024/0301-1526/a001258","url":null,"abstract":"<p><p><b></b> <i>Background:</i> Patients with intermittent claudication (IC) need lifelong treatment with secondary prevention, including smoking cessation, physical activity, and best medical treatment. The deficiency in existing support indicates a need for new strategies to improve self-management of the disease. However, knowledge of electronic health (e-health) as support for these patients is lacking. The primary aim was to evaluate the effect on secondary prevention outcomes and the usability of a web-based application for patients with IC. The secondary aim was to describe the patients' experiences of using a web-based application. <i>Patients and methods:</i> Patients with IC (n=34) were recruited from a vascular outpatient clinic to a randomized controlled pilot trial. The study population had a mean age of 73 years and 52.9% were women. For three months, the intervention group (n=18) reported information through/via the application about physical activity, smoking, medication therapy, blood pressure, pain after activity, and quality of life (QoL). Primary outcome was walking distance, and the secondary outcome included ankle brachial index (ABI), blood pressure measurements, lifestyle factors, health education, and QoL. A linear mixed model was used to determine how the intervention affected the progression of walking distance, ABI, blood pressure measurements and BMI and Wilcoxon signed ranked test for QoL. After completing the study, the intervention group was interviewed in focus groups. <i>Results:</i> The reporting adherence was high (86-93%). QoL were improved in the intervention group (p=.049), and the level of insight into their condition increased in both intervention<i>-</i> (p=.016) and control group (p=.014). No significant differences in variables walking distance, ABI, blood pressure or BMI were observed between the groups. The interviews show an overall positive experience of using the application. Some patients experienced that the application increased their motivation to adhere to lifestyle recommendations. <i>Conclusions:</i> High reporting adherence and improved QoL, together with the participants experiences, indicate that using e-health may support adherence to secondary prevention in patients with IC but needs to be further studied in a full-scale randomized controlled trial.</p>","PeriodicalId":23528,"journal":{"name":"Vasa-european Journal of Vascular Medicine","volume":" ","pages":""},"PeriodicalIF":2.4,"publicationDate":"2026-01-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145960265","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Radiofrequency vs mechanochemical ablation for small saphenous vein insufficiency.","authors":"Vincenzo Ardita, Ferdinando Benito Attilio Valente, Nicola Galati, Claudia Anselmi, Carlo Campesi, Matteo Bossi, Roberto Chiesa, Domenico Baccellieri","doi":"10.1024/0301-1526/a001261","DOIUrl":"https://doi.org/10.1024/0301-1526/a001261","url":null,"abstract":"<p><p><b></b> <i>Background:</i> Radiofrequency ablation (RFA) and mechanochemical ablation (MOCA) have emerged as less invasive alternatives to traditional surgical interventions, offering reduced recovery times and comparable efficacy. This study aims to compare the efficacy, safety, and patient-reported outcomes between RFA and MOCA in treating SSV insufficiency. <i>Materials and methods:</i> this is a retrospective, nonrandomized study that involved patients who underwent either RFA or MOCA between 2015 to 2019. Data collected included demographics, clinical grading, procedural specifics, and follow-up outcomes. The primary endpoint was the comparison of freedom from recanalization and freedom from reinterventions rates, while secondary endpoints focused on recurrences rates and clinical outcomes assessed by revised clinical severity score (rVCSS), and Aberdeen Varicose Vein Questionnaire (AVVQ). <i>Results:</i> A total of 132 limbs were treated (n=72 RFA; n=60 MOCA). Baseline demographics and clinical severity were comparable between groups. At 5 years, freedom from recanalization rate was significantly higher in the RFA group compared to the MOCA group (91.7% vs 66%; p=.0014). Clinical recurrence rates at 5 years were 11.7% for RFA and 22% for MOCA (p=.0023), while freedom from reintervention rates were 93.3% and 72.7%, respectively (p=.0011). Although both groups showed clinical improvement over time, patients treated with MOCA exhibited a significant worsening in rVCSS and AVVQ at 3 and 5 years compared to the RFA group (p<.0001). <i>Conclusions:</i> RFA demonstrates greater long-term stability, lower recurrence and reintervention rates compared to MOCA, suggesting it may be a preferable option for SSV insufficiency treatment in terms of durability and patient outcome.</p>","PeriodicalId":23528,"journal":{"name":"Vasa-european Journal of Vascular Medicine","volume":" ","pages":""},"PeriodicalIF":2.4,"publicationDate":"2026-01-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145960208","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Atherectomy-assisted treatment or balloon angioplasty for atherosclerotic common femoral artery disease?","authors":"Grigorios Korosoglou, Martin Andrassy, Marco V Usai, Arne Schwindt, Raphael Coscas, Bahaa Nasr, Konstantinos P Donas","doi":"10.1024/0301-1526/a001259","DOIUrl":"https://doi.org/10.1024/0301-1526/a001259","url":null,"abstract":"<p><p><b></b> <i>Background:</i> To compare atherectomy-assisted endovascular revascularization with balloon angioplasty for the treatment of common femoral artery disease (CFAD). <i>Materials and methods:</i> In a multi-centre retrospective research collaborative, data from consecutive patients who underwent endovascular revascularization of the groin were analysed. Primary endpoints were clinically driven target-lesion-revascularization (CD-TLR) and improvement of clinical symptoms by Rutherford categories (RC). Kaplan-Mayer analyses were used to evaluate these endpoints over time in patients undergoing atherectomy-assisted versus conventional endovascular treatment. In addition, retrospective case-control matching was performed, considering patient and lesion specific characteristics. Lesion calcification was assessed using the PACSS scoring system. <i>Results:</i> Of 225 patients, 179 (79.6%) underwent atherectomy-assisted treatment, whereas 46 (20.4%) underwent balloon angioplasty. Mean age was 72.0 (66.0-79.0) yrs, 139 patients (61.8%) had intermittent claudication and 84 (37.3%) had chronic limb-threatening ischemia (CLTI). Involvement of the deep femoral artery femoral was present in 137 (60.9%) cases, whereas lesion calcification was moderate to severe (PACSS 2-4) in most cases (88%). Atherectomy had low complication rates (perforation in one (0.6%) patient and distal embolization requiring re-intervention in 2 (0.9%) patients) and lower rates of bail-out stenting compared to angioplasty (5.1% versus 36.7%, p<.0001). No perforation or distal embolization was observed in the angioplasty group. After matching for patient and lesion characteristics CD-TLR (HR=4.0, 95%CI=1.0-15.0, p<.05) and RC improvement rates both favoured atherectomy (93.5% versus 73.1%, p<.05). <i>Conclusions:</i> Atherectomy-assisted endovascular revascularization of CFAD seems to be associated with lower stent placement and re-intervention rates compared to balloon angioplasty. Future prospective trials with longer follow-up duration are now warranted.</p>","PeriodicalId":23528,"journal":{"name":"Vasa-european Journal of Vascular Medicine","volume":" ","pages":""},"PeriodicalIF":2.4,"publicationDate":"2026-01-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145935319","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Safety and efficiency of the Gore Viabahn VBX as a bail-out option in complex vascular procedures.","authors":"Hagen Kerndl, Viktoria Peters, Alexander Hyhlik-Dürr, Dominik Liebetrau","doi":"10.1024/0301-1526/a001206","DOIUrl":"10.1024/0301-1526/a001206","url":null,"abstract":"<p><p><b></b> <i>Background:</i> Endovascular treatments in emergency or bailout situations focusing on anatomical regions with high extension and flexion movement remain a key area of interest. To date, the main field of application of the GORE^® VIABAHN^® VBX Balloon Expandable Endoprosthesis (VBX) (Gore, USA) has been in complex iliac occlusions and aortic pathologies. This retrospective study aimed to assess the safety and effectiveness of the VBX in a real-world patient population at a single centre, focusing on anatomical regions under high mechanical stress. This study presents the first data set for the VBX beyond its use in aortic and iliac pathologies. <i>Materials and methods:</i> In this retrospective monocentric study, all patients included had a Gore^® Viabahn^® balloon expandable (VBX^®) implanted at a tertiary referral hospital during the observation period 02/2020 to 03/2024. <i>Results:</i> The median population age was 69 years, and eight patients were female. The mean Body Mass Index was 26,2±4,9 kg/m². Eleven patients were treated in the inguinal region, nine in the shoulder region, and two in the knee region. The most common indications for implantation were stenosis (9/21) and bleeding (6/18). Eleven patients had an urgent need for implantation. Technical success was 100%. No stent-associated complication was observed. The 30-day mortality rate was 0%. The median follow-up time for all patients was 230 days (27-1064 d). Primary patency for all patients was 95,2%, while secondary patency was 100%. <i>Conclusions:</i> The VBX represents a safe and easy-to-use stent graft for managing complications, even in challenging anatomy regions.</p>","PeriodicalId":23528,"journal":{"name":"Vasa-european Journal of Vascular Medicine","volume":" ","pages":"49-55"},"PeriodicalIF":2.4,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144267324","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"From the societies.","authors":"","doi":"10.1024/0301-1526/a001263","DOIUrl":"https://doi.org/10.1024/0301-1526/a001263","url":null,"abstract":"","PeriodicalId":23528,"journal":{"name":"Vasa-european Journal of Vascular Medicine","volume":"55 1","pages":"69-74"},"PeriodicalIF":2.4,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145900957","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}